UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
XAIR
Beyond Air, Inc.
There isn't enough reported data to score XAIR yet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
XAIR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Unavailable | |
| Unavailable |
XAIR's revenue is currently healthy, but its profitability is under pressure. There isn't enough data to rate its cash flow and balance sheet.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
XAIR PE Valuation
XAIR has no meaningful PE right now: it lost money over the past year.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
XAIR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect XAIR's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the stronger earnings trend. Trailing diluted EPS is down 8.5% for UNH versus XAIR down 150%.
XAIR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2024 | -$424.00 | +$429.13 |
| Q3 2024 | -$564.00 | +$261.13 |
| Q2 2024 | -$656.00 | +$125.13 |
| Q1 2024 | -$728.00 | +$21.13 |
| Q4 2023 | -$853.13 | -$74.83 |
| Q3 2023 | -$825.13 | -$102.83 |
| Q2 2023 | -$781.13 | -$74.83 |
| Q1 2023 | -$749.13 | -$66.83 |
XAIR is still losing money, but far less than before: $424.00 per share over the past year, against $853.13 at its worst in late 2023.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
XAIR has the stronger quarterly revenue trend. Revenue is down 0.4% for UNH versus up 145% for XAIR.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
XAIR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2025 | $1.2M | +145% |
| Q4 2024 | $1.1M | +174% |
| Q3 2024 | $798K | +234% |
| Q2 2024 | $683K | +1058% |
| Q4 2020 | $148.8K | -53% |
XAIR's revenue has grown year over year for six quarters in a row: $1M last quarter, up 145% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2025 | -623% | +2065 points |
| Q4 2024 | -1022% | +3317 points |
| Q3 2024 | -1608% | +5729 points |
| Q2 2024 | -1988% | +24919 points |
| Q1 2024 | -2688% | N/A |
| Q4 2023 | -4338% | N/A |
| Q3 2023 | -7337% | N/A |
| Q2 2023 | -26907% | N/A |
XAIR's operating margin was −623% last quarter, up 2065 points from the same quarter a year ago, near the top of its range since 2019.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over XAIR on cash generation, producing positive trailing cash flow while its opponent burns cash.
XAIR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.3M | -$1.6M |
| Q2 2026 | -$5.2M | -$430K |
| Q1 2026 | -$5.5M | +$3M |
| Q4 2025 | -$4.3M | +$4M |
| Q3 2025 | -$4.7M | +$9.8M |
| Q2 2025 | -$4.7M | +$8.1M |
| Q1 2025 | -$8.5M | +$4.2M |
| Q4 2024 | -$8.3M | +$6.9M |
XAIR has burned cash in almost every quarter: −$21M over the past year, against −$26M the year before.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over XAIR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
XAIR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +188% | +1.4M shares |
| 1 year | +729% | +1.8M shares |
| 3 years | +2679% | +2M shares |
| 5 years | +4757% | +2M shares |
XAIR has 2M diluted shares, up 729% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2020 | — |
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
XAIR Net Leverage
XAIR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
XAIR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.2 | Oversold |
| Stochastic | 4.0 | Oversold |
XAIR's weekly RSI is 27 (oversold) and its Stochastic is 4 (oversold).
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
XAIR PE vs Healthcare Sector
XAIR has no meaningful PE right now: it lost money over the past year.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over XAIR on trend strength, trading above more of its moving averages.
XAIR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.35 | 6% below |
| 20 week MA | $4.18 | 47% below |
| 50 week MA | $11.3 | 80% below |
| 100 week MA | $48.1 | 95% below |
| 200 week MA | $542.0 | 100% below |
XAIR is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over XAIR on returns for 2026, with the stronger performance.
XAIR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1,752.0 | $2,084.0 | +19% |
| 2021 | $2,084.0 | $3,916.0 | +88% |
| 2022 | $3,916.0 | $2,496.0 | -36% |
| 2023 | $2,496.0 | $784.0 | -69% |
| 2024 | $784.0 | $176.0 | -78% |
| 2025 | $176.0 | $15.0 | -91% |
| 2026 YTD | $15.0 | $2.21 | -85% |
XAIR has finished four years in a row lower, and it's down 85% so far in 2026.